Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483785A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003CA2483778A1 Biomatrix structural containment and fixation systems and methods of use thereof
11/13/2003CA2483656A1 Reduced formate poly(alkylene oxide) for a controlled release dosage form of reboxetine
11/13/2003CA2483655A1 Methods and dosage forms for controlled delivery of oxycodone
11/13/2003CA2483653A1 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2483569A1 Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
11/13/2003CA2483566A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
11/13/2003CA2483538A1 Bicyclic 6-alkylidene-penems as .szlig.-lactamases inhibitors
11/13/2003CA2483532A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
11/13/2003CA2483529A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/13/2003CA2483456A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/13/2003CA2483275A1 Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
11/13/2003CA2483120A1 Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome
11/13/2003CA2483084A1 Tyrosine kinase inhibitors
11/13/2003CA2483054A1 Carvedilol monocitrate monohydrate
11/13/2003CA2483001A1 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
11/13/2003CA2482997A1 Further syntheses of cyproterone acetate
11/13/2003CA2482789A1 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treatglaucomatous retinopathies/optic neuropathies
11/13/2003CA2482784A1 Composition for treating cancer containing n,n-dimethylphytosphingosine
11/13/2003CA2482524A1 Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
11/13/2003CA2481322A1 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
11/13/2003CA2480008A1 Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
11/13/2003CA2471988A1 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells
11/13/2003CA2462879A1 Immunoconjugates for the treatment of tumours
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003WO2003093219A1 NOVEL PHENYLETHANOLAMINE COMPOUNDS HAVING β2-ACCEPTOR EXCITATORY FUNCTION AND THEIR PREPARATION METHOD
11/12/2003EP1361227A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1361223A1 Method of manufacture of 1,3-oxathiolane nucleosides
11/12/2003EP1361220A1 Cyclic compounds having thrombopoietin receptor agonism
11/12/2003EP1361213A1 Process for preparation of cyanophenylbenzoic acid derivatives
11/12/2003EP1361212A1 Peptide derivatives as antithrombotic agents
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360967A1 Coated medical devices
11/12/2003EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
11/12/2003EP1360963A2 Ganglioside-KLH conjugate vaccines with QS-21
11/12/2003EP1360960A1 Use of ketoconazole and related substances in medicaments for treatment of type II diabetes
11/12/2003EP1360959A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/12/2003EP1360957A1 Vitamin/mineral complex
11/12/2003EP1360896A2 Animal brush
11/12/2003EP1360508A2 Prediction of wound healing by urinary nitrate assay
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360319A2 Diagnosis of diseases associated with metabolism
11/12/2003EP1360299A2 The genome of a bifidobacterium
11/12/2003EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360198A2 Novel polypeptides and nucleic acids encoded thereby
11/12/2003EP1360189A1 Formulation of boronic acid compounds
11/12/2003EP1360187A1 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias
11/12/2003EP1360186A2 Carboline derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360182A1 4-aminobenzopyran derivatives
11/12/2003EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360172A1 Ppar agonists
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1360169A2 Succinate salt of o-desmethyl-venlafaxine
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359979A2 Anti cancer combination of substituted pyrroles and paclitaxel
11/12/2003EP1359943A2 Biotin-derivates and their conjugates with chelating agents
11/12/2003EP1359942A1 Targetted anti-tumor drug delivery systems
11/12/2003EP1359940A2 Combinations of statins, estrogenic agents and optionally estrogens
11/12/2003EP1359933A2 Treatment of demyelinating diseases by administering gpe
11/12/2003EP1359928A1 Medicinal and cosmetic use of hop and co-enzyme q10
11/12/2003EP1359922A1 Novel receptors for $i(helicobacter pylori) and use thereof
11/12/2003EP1359921A2 Methods to treat autoimmune and inflammatory conditions
11/12/2003EP1359920A2 Methods and formulations for the treatment of female sexual dysfunction
11/12/2003EP1359919A1 Method of treating substance abuse with quetiapine
11/12/2003EP1359918A1 Method for treating glaucoma iiib
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1359914A2 Novel therapeutic use of a thienylcyclohexylamine derivative
11/12/2003EP1359913A1 Thrombin inhibitors
11/12/2003EP1359912A2 Novel methods using pyridine derivatives
11/12/2003EP1359911A2 Method for treating fibrotic diseases or other indications ivc
11/12/2003EP1359910A1 Method for treating glaucoma ii b
11/12/2003EP1359909A2 Anticancer treatment using triptolide prodrugs
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1359905A2 Use of mglur5 antagonists for the treatment of pruritic conditions
11/12/2003EP1359904A2 P27 prevents cellular migration
11/12/2003EP1359902A2 Bimodal dry powder formulation for inhalation
11/12/2003EP1359900A1 A stable pharmaceutical formulation comprising torsemide modification ii
11/12/2003EP1359897A2 Cosmetic composition and method for reducing or preventing wrinkling
11/12/2003EP1359885A1 Nos inhibitors for treatment of wrinkles
11/12/2003EP1359881A1 Process and container with low oxygen content and further containing mas
11/12/2003EP1359816A1 Combination of probiotics
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1280813B1 Anti-viral pyrimidine nucleoside analogues
11/12/2003EP1255564B1 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
11/12/2003EP1244438B1 Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
11/12/2003EP1242402B1 Novel compounds
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
1 ... 5279 5280 5281 5282 5283 5284 5285 5286 5287 5288 5289 5290 5291 5292 5293 5294 5295 5296 5297 5298 5299 ... 7860